United States · FDA National Drug Code directory
Cerebrapar
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44911-0317_c63dccf3-5bbf-4a26-885f-f9c3de29cf4c
- Product NDC
- 44911-0317
- Form
- LIQUID
- Composition / generic term
- Baptisia Tinctoria, Cerebrum Suis, Secale Cornutum, Baryta Carbonica, Calcarea Carbonica, Gelsemium Sempervirens, Kali Phosphoricum, Lycopodium Clavatum, Staphysagria
- Labeler
- Energique, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20160111
- Source listing expiry
- 20261231
Source-listed ingredients
- BAPTISIA TINCTORIA ROOT — 3 [hp_X]/mL
- SUS SCROFA CEREBRUM — 6 [hp_X]/mL
- CLAVICEPS PURPUREA SCLEROTIUM — 6 [hp_X]/mL
- BARIUM CARBONATE — 12 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE — 12 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT — 12 [hp_X]/mL
- POTASSIUM PHOSPHATE, DIBASIC — 12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE — 12 [hp_X]/mL
- DELPHINIUM STAPHISAGRIA SEED — 12 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (44911-0317-1) · 44911-0317-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →